CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer

Genome Research

Volumn 23, Issue 9, 2013, Pages 1446-1461

  Ling, Hui ^a   Spizzo, Riccardo ^a,q   Atlasi, Yaser ^b   Nicoloso, Milena ^a   Shimizu, Masayoshi ^a   Redis, Roxana S ^a,c   Nishida, Naohiro ^a,d   Gafà, Roberta ^e   Song, Jian ^a   Guo, Zhiyi ^a   Ivan, Cristina ^a   Barbarotto, Elisa ^a   De Vries, Ingrid ^b   Zhang, Xinna ^a   Ferracin, Manuela ^e   Churchman, Mike ^f   Van Galen, Janneke F ^b   Beverloo, Berna H ^b   Shariati, Maryam ^a   Haderk, Franziska ^a,r   Estecio, Marcos R ^a   Garcia Manero, Guillermo ^a   Patijn, Gijs A ^b   Gotley, David C ^g   Bhardwaj, Vikas ^a   Shureiqi, Imad ^a   Sen, Subrata ^a   Multani, Asha S ^a   Welsh, James ^a   Yamamoto, Ken ^h   Taniguchi, Itsuki ^h   Song, Min Ae ⁱ   Gallinger, Steven ^j   Casey, Graham ^k   Thibodeau, Stephen N ^l   Le Marchand, Loic ^m   Tiirikainen, Maarit ^m   Mani, Sendurai A ^a   Zhang, Wei ^a   Davuluri, Ramana V ⁿ   Mimori, Koshi ^o   Mori, Masaki ^d   Sieuwerts, Anieta M ^p   Martens, John W M ^p   Tomlinson, Ian ^f   Negrini, Massimo ^e   Berindan Neagoe, Ioana ^c   Foekens, John A ^p   Hamilton, Stanley R ^a   Lanza, Giovanni ^e   Kopetz, Scott ^a   Fodde, Riccardo ^b   Calin, George A ^a   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^c IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF FERRARA   (Italy)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g PRINCESS ALEXANDRA HOSPITAL   (Australia)

^h KYUSHU UNIVERSITY   (Japan)

ⁱ UNIVERSITY OF HAWAII   (United States)

^j MOUNT SINAI HOSPITAL   (Canada)

^k UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^l MAYO CLINIC   (United States)

^m UNIVERSITY OF HAWAII CANCER CENTER   (United States)

ⁿ WISTAR INSTITUTE   (United States)

^o KYUSHU UNIVERSITY BEPPU HOSPITAL   (Japan)

^p ERASMUS MEDICAL CENTER   (Netherlands)

^q CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^r GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CCAT2; LONG UNTRANSLATED RNA; MICRORNA 20A; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CANCER GROWTH; CHROMOSOMAL INSTABILITY; COLORECTAL CANCER; CONTROLLED STUDY; FEEDBACK SYSTEM; FEMALE; GENE MAPPING; HUMAN; HUMAN CELL; INTERACTIONS WITH RNA; MAJOR CLINICAL STUDY; METASTASIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CHROMOSOMAL INSTABILITY; CHROMOSOMES, HUMAN, PAIR 8; COLONIC NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICRORNAS; NEOPLASM METASTASIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-MYC; RNA, LONG NONCODING; TRANSCRIPTION FACTOR 7-LIKE 1 PROTEIN; TRANSCRIPTION, GENETIC; WNT SIGNALING PATHWAY;

EID: 84883736533     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.152942.112     Document Type: Article

References (54)

1. Ambros V. 2001. microRNAs: Tiny regulators with great potential. Cell 107: 823-826.
2. Aoki K, Aoki M, Sugai M, Harada N, Miyoshi H, Tsukamoto T, Mizoshita T, Tatematsu M, Seno H, Chiba T, et al. 2007. Chromosomal instability by b-catenin/TCF transcription in APC or b-catenin mutant cells. Oncogene 26: 3511-3520.
3. Bartley AN, Yao H, Barkoh BA, Ivan C, Mishra BM, Rashid A, Calin GA, Luthra R, Hamilton SR. 2011. Complex patterns of altered microRNA expression during the adenoma-adenocarcinoma sequence for microsatellite-stable colorectal cancer. Clin Cancer Res 17: 7283-7293.
4. Bejerano G, Pheasant M, Makunin I, Stephen S, Kent WJ, Mattick JS, Haussler D. 2004. Ultraconserved elements in the human genome. Science 304: 1321-1325.
5. Bertucci F, Lagarde A, Ferrari A, Finetti P, Charafe-Jauffret E, Van Laere S, Adelaide J, Viens P, Thomas G, Birnbaum D, et al. 2012. 8q24 cancer risk allele associated with major metastatic risk in inflammatory breast cancer. PLoS ONE 7: e37943.
6. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B. 1998. Mutations of mitotic checkpoint genes in human cancers. Nature 392: 300-303.
7. Calin GA, Liu CG, Ferracin M, Hyslop T, Spizzo R, Sevignani C, Fabbri M, Cimmino A, Lee EJ, Wojcik SE, et al. 2007. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell 12: 215-229.
8. Camps J, Morales C, Prat E, Ribas M, Capella G, Egozcue J, Peinado MA, Miro R. 2004. Genetic evolution in colon cancer KM12 cells and metastatic derivates. Int J Cancer 110: 869-874.
9. The Cancer Genome Atlas Network. 2012. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487: 330-337.
10. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, Dang CV, Thomas-Tikhonenko A, Mendell JT. 2008. Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet 40: 43-50.
11. Clevers H. 2006. Wnt/b-catenin signaling in development and disease. Cell 127: 469-480.
12. Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, Tanzer A, Lagarde J, LinW, Schlesinger F, et al. 2012. Landscape of transcription in human cells. Nature 489: 101-108.
13. Fakhrai-Rad H, Pourmand N, Ronaghi M. 2002. Pyrosequencing: An accurate detection platform for single nucleotide polymorphisms. Hum Mutat 19: 479-485.
14. Felsher DW, Bishop JM. 1999. Transient excess of MYC activity can elicit genomic instability and tumorigenesis. Proc Natl Acad Sci 96: 3940-3944.
15. Feng X, Wu Z, Wu Y, Hankey W, Prior TW, Li L, Ganju RK, Shen R, Zou X. 2011. Cdc25A regulates matrix metalloprotease 1 through Foxo1 and mediates metastasis of breast cancer cells. Mol Cell Biol 31: 3457-3471.
16. Fodde R, Kuipers J, Rosenberg C, Smits R, Kielman M, Gaspar C, van Es JH, Breukel C, Wiegant J, Giles RH, et al. 2001. Mutations in the APC tumour suppressor gene cause chromosomal instability. Nat Cell Biol 3: 433-438.
17. Galaktionov K, Chen X, Beach D. 1996. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382: 511-517.
18. Ghoussaini M, Song H, Koessler T, Al Olama AA, Kote-Jarai Z, Driver KE, Pooley KA, Ramus SJ, Kjaer SK, Hogdall E, et al. 2008. Multiple loci with different cancer specificities within the 8q24 gene desert. J Natl Cancer Inst 100: 962-966.
19. Gilles C, Polette M, Mestdagt M, Nawrocki-Raby B, Ruggeri P, Birembaut P, Foidart JM. 2003. Transactivation of vimentin by b-catenin in human breast cancer cells. Cancer Res 63: 2658-2664.
20. Hadjihannas MV, Bruckner M, Jerchow B, Birchmeier W, Dietmaier W, Behrens J. 2006. Aberrant Wnt/b-catenin signaling can induce chromosomal instability in colon cancer. Proc Natl Acad Sci 103: 10747-10752.
21. Haiman CA, Le Marchand L, Yamamato J, Stram DO, Sheng X, Kolonel LN, Wu AH, Reich D, Henderson BE. 2007. A common genetic risk factor for colorectal and prostate cancer. Nat Genet 39: 954-956.
22. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW. 1998. Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512.
23. Heuberger J, Birchmeier W. 2010. Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb Perspect Biol 2: a002915.
24. Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F. 2002. Wnt/b-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 22: 1172-1183.
25. Kaplan KB, Burds AA, Swedlow JR, Bekir SS, Sorger PK, Nathke IS. 2001. A role for the Adenomatous Polyposis Coli protein in chromosome segregation. Nat Cell Biol 3: 429-432.
26. Lengauer C, KinzlerKW, Vogelstein B. 1997.Genetic instability in colorectal cancers. Nature 386: 623-627.
27. Li C, Kim SW, Rai D, Bolla AR, Adhvaryu S, Kinney MC, Robetorye RS, Aguiar RC. 2009. Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma. Blood 113: 6681-6690.
28. Lin MF, Jungreis I, Kellis M. 2011. PhyloCSF: A comparative genomics method to distinguish protein coding and non-coding regions. Bioinformatics 27: i275-i282.
29. Liu H, Radisky DC, Yang D, Xu R, Radisky ES, Bissell MJ, Bishop JM. 2012. MYC suppresses cancer metastasis by direct transcriptional silencing of av and b3 integrin subunits. Nat Cell Biol 14: 567-574.
30. Lustig B, Jerchow B, Sachs M, Weiler S, Pietsch T, Karsten U, van deWetering M, Clevers H, Schlag PM, Birchmeier W, et al. 2002. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol Cell Biol 22: 1184-1193.
31. Mitchell KO, Ricci MS, Miyashita T, Dicker DT, Jin Z, Reed JC, El-Deiry WS. 2000. Bax is a transcriptional target and mediator of c-myc-induced apoptosis. Cancer Res 60: 6318-6325.
32. Nguyen DX, Chiang AC, Zhang XH, Kim JY, Kris MG, Ladanyi M, Gerald WL, Massague J. 2009. WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell 138: 51-62.
33. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. 2005. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843.
34. Orom UA, Derrien T, Beringer M, Gumireddy K, Gardini A, Bussotti G, Lai F, Zytnicki M, Notredame C, Huang Q, et al. 2010. Long noncoding RNAs with enhancer-like function in human cells. Cell 143: 46-58.
35. Pomerantz MM, Ahmadiyeh N, Jia L, Herman P, Verzi MP, Doddapaneni H, Beckwith CA, Chan JA, Hills A, Davis M, et al. 2009. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet 41: 882-884.
36. Rinn JL, Chang HY. 2012. Genome regulation by long noncoding RNAs. Annu Rev Biochem 81: 145-166.
37. Sansom OJ, Meniel VS, Muncan V, Phesse TJ, Wilkins JA, Reed KR, Vass JK, Athineos D, Clevers H, Clarke AR. 2007. Myc deletion rescues Apc deficiency in the small intestine. Nature 446: 676-679.
38. Sieuwerts AM, Usher PA, Meijer-van Gelder ME, Timmermans M, Martens JW, Brunner N, Klijn JG, Offenberg H, Foekens JA. 2007. Concentrations of TIMP1 mRNA splice variants and TIMP-1 protein are differentially associated with prognosis in primary breast cancer. Clin Chem 53: 1280-1288.
39. Smid M, Hoes M, Sieuwerts AM, Sleijfer S, Zhang Y, Wang Y, Foekens JA, Martens JW. 2011. Patterns and incidence of chromosomal instability and their prognostic relevance in breast cancer subtypes. Breast Cancer Res Treat 128: 23-30.
40. Sotelo J, Esposito D, Duhagon MA, Banfield K, Mehalko J, Liao H, Stephens RM, Harris TJ, Munroe DJ, Wu X. 2010. Long-range enhancers on 8q24 regulate c-Myc. Proc Natl Acad Sci 107: 3001-3005.
41. SpannuthWA, Nick AM, Jennings NB, Armaiz-Pena GN, Mangala LS, Danes CG, Lin YG, Merritt WM, Thaker PH, Kamat AA, et al. 2009. Functional significance of VEGFR-2 on ovarian cancer cells. Int J Cancer 124: 1045-1053.
42. Spizzo R, Nicoloso MS, Croce CM, Calin GA. 2009. SnapShot: MicroRNAs in Cancer. Cell 137: 586.
43. Sur IK, Hallikas O, Vaharautio A, Yan J, Turunen M, Enge M, Taipale M, Karhu A, Aaltonen LA, Taipale J. 2012. Mice lacking a Myc enhancer that includes human SNP rs6983267 are resistant to intestinal tumors. Science 338: 1360-1363.
44. Takatsuno Y, Mimori K, Yamamoto K, Sato T, Niida A, Inoue H, Imoto S, Kawano S, Yamaguchi R, Toh H, et al. 2012. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal cancer. Ann Surg Oncol 20: 1395-1402.
45. Tomlinson I, Webb E, Carvajal-Carmona L, Broderick P, Kemp Z, Spain S, Penegar S, Chandler I, Gorman M, Wood W, et al. 2007. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet 39: 984-988.
46. Tuupanen S, Turunen M, Lehtonen R, Hallikas O, Vanharanta S, Kivioja T, Bjorklund M, Wei G, Yan J, Niittymaki I, et al. 2009. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat Genet 41: 885-890.
47. Wang H, Elbein SC. 2007. Detection of allelic imbalance in gene expression using Pyrosequencing. Methods Mol Biol 373: 157-176.
48. Wang L, Park HJ, Dasari S, Wang S, Kocher JP, Li W. 2013. CPAT: Coding- Potential Assessment Tool using an alignment-free logistic regression model. Nucleic Acids Res 41: e74.
49. Watanabe T, Kobunai T, Yamamoto Y, Matsuda K, Ishihara S, Nozawa K, Yamada H, Hayama T, Inoue E, Tamura J, et al. 2012. Chromosomal instability (CIN) phenotype, CIN high or CIN low, predicts survival for colorectal cancer. J Clin Oncol 30: 2256-2264.
50. Wielenga VJ, Smits R, Korinek V, Smit L, Kielman M, Fodde R, Clevers H, Pals ST. 1999. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol 154: 515-523.
51. Wojcik SE, Rossi S, Shimizu M, Nicoloso MS, Cimmino A, Alder H, Herlea V, Rassenti LZ, Rai KR, Kipps TJ, et al. 2010. Non-coding RNA sequence variations in human chronic lymphocytic leukemia and colorectal cancer. Carcinogenesis 31: 208-215.
52. Yu M, Ting DT, Stott SL, Wittner BS, Ozsolak F, Paul S, Ciciliano JC, SmasME, Winokur D, Gilman AJ, et al. 2012. RNA sequencing of pancreatic circulating tumour cells implicates WNTsignalling inmetastasis. Nature 487: 510-513.
53. Zhang J, Xiao Z, Lai D, Sun J, He C, Chu Z, Ye H, Chen S, Wang J. 2012. miR- 21, miR-17 and miR-19a induced by phosphatase of regenerating liver-3 promote the proliferation and metastasis of colon cancer. Br J Cancer 107: 352-359.
54. Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ, Roussel MF. 1998. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev 12: 2424-2433.